Subramanian, C.; Spielbauer, K.K.; Pearce, R.; Kovatch, K.J.; Prince, M.E.; Timmermann, B.N.; Cohen, M.S.
Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Nutrients 2022, 14, 5398.
https://doi.org/10.3390/nu14245398
AMA Style
Subramanian C, Spielbauer KK, Pearce R, Kovatch KJ, Prince ME, Timmermann BN, Cohen MS.
Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Nutrients. 2022; 14(24):5398.
https://doi.org/10.3390/nu14245398
Chicago/Turabian Style
Subramanian, Chitra, Katie K. Spielbauer, Robin Pearce, Kevin J. Kovatch, Mark E. Prince, Barbara N. Timmermann, and Mark S. Cohen.
2022. "Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma" Nutrients 14, no. 24: 5398.
https://doi.org/10.3390/nu14245398
APA Style
Subramanian, C., Spielbauer, K. K., Pearce, R., Kovatch, K. J., Prince, M. E., Timmermann, B. N., & Cohen, M. S.
(2022). Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Nutrients, 14(24), 5398.
https://doi.org/10.3390/nu14245398
